USPTO serial 79266965
PRINT PLATFORM FOR REVOLUTIONARY IDENTIFICATION & ISOLATION OF NOVEL TARGETS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- KENEALY, NATALIE LANGFORD
- Law office
- TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PRINT PLATFORM FOR REVOLUTIONARY IDENTIFICATION & ISOLATION OF NOVEL TARGETS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of viral diseases; anti-inflammatory analgesic preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; capsules for medicines; gastro-intestinal treatment preparations; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; medical diagnostic test strips; diagnostic test reagents for medical purposes; in vitro diagnostic preparations for medical purposes; diagnostic reagents for medicinal use; pharmaceuticals; clinical diagnostic reagents; pharmaceutical preparations for use in the targeted therapy of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for use in oncology; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis; radio-isotope markers for therapeutic or diagnostic use; therapeutic drugs and agents; dermatological pharmaceutical products; tumor suppressing agents; pharmaceutical preparations for respiratory organs | ACTIVE | — |
| 042 | Research and development of vaccines and medicines; drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical products development; research on the subject of pharmaceuticals; pharmaceutical products evaluation; pharmaceutical drug development services; medicine research; medical product testing; laboratory research services relating to pharmaceuticals; research in the field of medical products; consultancy in the field of testing, inspection, research of medical products; providing information on the testing, inspection, research of medical products; scientific research in the fields of medicine, health and pharmacology; consultation and providing information in the field of pharmacology; analysis and evaluation of medical product development; research in the field of target identification of tumors; research and development services in the field of medical preparations and technology for targeted therapy of tumors; research in the field of diagnostic target identification | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 4, 2021 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 14, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 12, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 2, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 14, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 12, 2020 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 12, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 26, 2019 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Nov 20, 2019 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Nov 15, 2019 | RINX | USPTO CORRECTION PROCESSED BY IB | — |
| Nov 15, 2019 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 9, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 13, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 12, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 4, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 3, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 12, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |